Market Place
Sourcing Support
Biodexa Updates On MTX110 Phase 1 Study In Glioblastoma
04 Oct 2024 //
GLOBENEWSWIRE
FDA`s ODAC to review accelerated approvals for multiple myeloma, leukemia
24 Sep 2021 //
ENDPTS
Secura Bio Announces New Data Regarding the Combination of FARYDAK®
02 Feb 2021 //
PRNEWSWIRE
Secura Bio Acquires Global Rights To Farydak®
12 Mar 2019 //
PR NEWSWIRE
J&J gets CHMP backing for broader Darzalex use
27 Feb 2017 //
PMLIVE
What Puts a New Drug Launch in Line for Victory? Ask Gilead, Biogen and J&J
18 Nov 2016 //
FIERCE PHARMA
Independent group finds multiple myeloma drugs too costly in U.S
07 May 2016 //
REUTERS
Empliciti on track for European approval in multiple myeloma
03 Feb 2016 //
PM LIVE
NHS cancer patients gain access to four new therapies
27 Jan 2016 //
PHARMATIMES
Ash Stevens to make API for Takeda`s new oral blood cancer drug
24 Nov 2015 //
IN-PHARMA TECHNOLOGIST
Takeda`s `breakthrough` Velcade heir wins early FDA approval in myeloma
20 Nov 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.